Search

everythinglearnresearchcommunity

for

Search:↓

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

Targeted therapies promoting differentiation could help treat basal cell carcinoma by exhausting cancer stem cells.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Hair follicle melanocytes die during hair regression.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Wnt-10b helps skin cells and hair grow.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Noggin promotes skin tumors by activating certain cell signaling pathways.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

ABCG2 protein marks stem-like skin cells in human epidermis.

Mice skin matures by day 200, leading to aging signs like curved hair follicles and white hairs due to changes in skin stem cells.

Raman spectroscopy could effectively guide skin cancer surgery by identifying tumor margins.

High-dose radiation speeds up aging in skin stem cells.

LRIG1 is linked to better survival in Merkel cell carcinoma.

The document updated knowledge on skin disorders, focusing on unusual moles in older adults, the progression from moles to melanoma, and evolving hair loss treatments.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Melasma results from changes in the skin's pigment and structure, not just pigment cell growth.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Higher doses of Tribulus terrestris extract increase MC-1R expression in mouse hair follicles.

The woman's widespread skin condition did not improve despite various treatments.

The treatment improved hair color in most vitiligo patients without major side effects.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.